An analysis of the SFSTP guide on validation of chromatographic bioanalytical methods: progresses and limitations

被引:128
作者
Boulanger, B
Chiap, P
Dewe, W
Crommen, J
Hubert, P
机构
[1] Univ Liege, CHU Liege, Inst Pharm, Dept Pharmaceut Analyt Chem, B-4000 Liege 1, Belgium
[2] Lilly Dev Ctr, Stat & Math Sci, B-1348 Mont St Guibert, Belgium
关键词
bioanalysis; method validation; statistics;
D O I
10.1016/S0731-7085(03)00182-1
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The Societe Francaise des Sciences et Techniques Pharmaceutiques (SFSTP) published in 1997 a guide on the validation of chromatographic bio-analytical methods, which introduces new concepts in three different areas: stages of the validation, test of acceptability of a method and design of experiments to perform. In 'stages of validation', the SFSTP guide requires two phases to validate a method. The first phase, called 'prevalidation', is intended to (1) identify the model to use for the calibration curve; (2) evaluate the limits of quantitation; and (3) provide good estimates of the precision and bias of the method before designing the 'validation' phase per se. In the 'test of acceptability', the use of the interval hypotheses is envisaged by the SFSTP guide, not on the parameters of bias and precision, but on individual results by mixing mean bias and intermediate precision in a single test. The SFSTP guide also avoids the use of Satterthwaite's df for testing the acceptability. The reasons for those choices are discussed extensively. In 'design of experiments', much effort has been devoted to improving the quality of results by optimally designing and sizing the experiments to perform in validation. The rationale for using near D-optimal designs for the calibration curve is demonstrated and sample sizes are proposed to correctly size the validation experiments. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:753 / 765
页数:13
相关论文
共 18 条
  • [1] Atkinson AC., 1992, OPTIMUM EXPT DESIGN
  • [2] CHAPUZET E, 1998, STP PHARM PRATIQUES, V8, P81
  • [3] Chapuzet E., 1997, STP Pharma Pratiques, V7, P169
  • [4] Validation of an automated method for the liquid chromatographic determination of atenolol in plasma: application of a new validation protocol
    Chiap, P
    Hubert, P
    Boulanger, B
    Crommen, J
    [J]. ANALYTICA CHIMICA ACTA, 1999, 391 (02) : 227 - 238
  • [5] CHOW SC, 1995, STAT TXB MONOGRAPHS, V143
  • [6] AN ANALYSIS OF THE WASHINGTON CONFERENCE REPORT ON BIOANALYTICAL METHOD VALIDATION
    HARTMANN, C
    MASSART, DL
    MCDOWALL, RD
    [J]. JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1994, 12 (11) : 1337 - 1343
  • [7] REAPPRAISAL OF HYPOTHESIS-TESTING FOR METHOD VALIDATION - DETECTION OF SYSTEMATIC-ERROR BY COMPARING THE MEANS OF 2 METHODS OR OF 2 LABORATORIES
    HARTMANN, C
    SMEYERSVERBEKE, J
    PENNINCKX, W
    VANDERHEYDEN, Y
    VANKEERBERGHEN, P
    MASSART, DL
    [J]. ANALYTICAL CHEMISTRY, 1995, 67 (24) : 4491 - 4499
  • [8] The SFSTP guide on the validation of chromatographic methods for drug bioanalysis: from the Washington Conference to the laboratory
    Hubert, P
    Chiap, P
    Crommen, J
    Boulanger, B
    Chapuzet, E
    Mercier, N
    Bervoas-Martin, S
    Chevalier, P
    Grandjean, D
    Lagorce, P
    Lallier, M
    Laparra, MC
    Laurentie, M
    Nivet, JC
    [J]. ANALYTICA CHIMICA ACTA, 1999, 391 (02) : 135 - 148
  • [9] ICH, 1997, FED REG, V62, P27463
  • [10] IFPMA, 1995, FED REGISTER, V60, P11260